PSI Sci
New here? Follow the money and the votes · Not sure of your district? Find your U.S. House member · Find your state legislators

H.R. 7071: Accelerating Access to Critical Therapies for ALS Act

Before you vote › Federal bills

H.R. 7071: Accelerating Access to Critical Therapies for ALS Act

116th Congress · introduced 2020-06-01 · Health · Latest: Referred to the House Committee on Energy and Commerce.

AI-relatedfederal

Follow this bill, step by step

  1. Where it came from: introduced 2020-06-01 · official record
  2. Who proposed it: Rep. Fortenberry, Jeff [R-NE-1] · what a sponsor is
  3. What happened next: no floor votes in our records yet. Why?
  4. Where it stands now: Referred to the House Committee on Energy and Commerce. Not final yet: this can still change. We check for updates every day.
  5. If it becomes law and spends money: follow the money to money laws, then agencies and contracts and grants.

What does this mean?

Official title

Accelerating Access to Critical Therapies for ALS Act

Plain summary

Accelerating Access to Critical Therapies for ALS Act This bill establishes a grant program, as well as a new center within the Food and Drug Administration (FDA), to facilitate access to investigational therapies for neurodegenerative diseases such as amyotrophic lateral sclerosis (i.e., ALS, also known as Lou Gehrig's disease, a progressive and fatal disease). Specifically, the Department of Health and Human Services (HHS) must award grants for the provision of investigational drugs for ALS and other rapidly progressing neurodegenerative diseases through an expanded access (i.e., compassionate use) program. HHS may award these grants to (1) a small business that is the sponsor of an investigational new drug application, or (2) a participating clinical trial site for such a sponsor. Additionally, HHS must establish within the FDA a Center of Excellence for Neurodegenerative Diseases. The center shall have duties and authorities similar to those of the FDA's Oncology Center of Excellence, which helps expedite the development of medical products and assists providers in requesting access to investigational drugs.

Congressional Research Service summary (Introduced in House), quoted unchanged (nonpartisan). Read the source.

What a vote does

A “Yea” vote

If it passes both chambers and is signed, it becomes law.

A “Nay” vote

If it is not passed, current law stays as it is.

PSI Sci description of the legislative step (not an opinion).

What does this mean? (plain words)

Official text

Accelerating Access to Critical Therapies for ALS Act

Source: Congressional Research Service summary (Introduced in House)

AI explanation – may be wrong, check the official text

No AI explanation yet. It takes up to a minute to write and is then saved for everyone.

Limited to a few requests an hour per person.

The strongest published arguments

Arguments for (supporters)

Needs sources: no published arguments on this side yet. We only show items backed by a published source. Suggest one.

Arguments against (opponents)

Needs sources: no published arguments on this side yet. We only show items backed by a published source. Suggest one.

Alternatives

Needs sources: no published alternatives yet (for example a different bill, a law instead of an amendment, or keeping current law). We only show items backed by a published source. Suggest one.

How did my representative vote? · This bill's floor votes

Officials and money

Sponsor: Rep. Fortenberry, Jeff [R-NE-1] · 198 cosponsors

Cost estimate: No cost estimate published yet.

Cosponsors on this site

Mike Quigley (D-IL), Clay Higgins (R-LA), David Schweikert (R-AZ), Jason Crow (D-CO), Terri A. Sewell (D-AL), Brian K. Fitzpatrick (R-PA), Ken Calvert (R-CA), J. French Hill (R-AR), Joe Neguse (D-CO), Eric A. "Rick" Crawford (R-AR), Andy Harris (R-MD), Steve Womack (R-AR), Tom Cole (R-OK), Charles J. "Chuck" Fleischmann (R-TN), Jefferson Van Drew (R-NJ), Joyce Beatty (D-OH), Jared F. Golden (D-ME), Mary Gay Scanlon (D-PA), Bruce Westerman (R-AR), Greg Stanton (D-AZ), William R. Timmons IV (R-SC), John R. Moolenaar (R-MI), Gregory W. Meeks (D-NY), Michael R. Turner (R-OH), Tom McClintock (R-CA), Scott DesJarlais (R-TN), Al Green (D-TX), Darren Soto (D-FL), Gilbert Ray Cisneros, Jr. (D-CA), Rashida Tlaib (D-MI), Ro Khanna (D-CA), Brian Babin (R-TX), Angie Craig (D-MN), Ted Lieu (D-CA), Betty McCollum (D-MN), Jason Smith (R-MO), Carol D. Miller (R-WV) and 138 more.

No linked floor roll calls in our collected records yet. This does not mean the bill has never had a vote. Check the official bill history.

Words on this page, explained (1)
Bill
A proposed law. It becomes law only if it passes the legislature and is signed by the president or governor (or a veto is overridden).

Plain meanings written from linked sources. All words.

Sources

Record fed-us-cong116-hr7071 · catalog fed-us-congress-bills-cong116 · updated 2026-11-15 by psicol fed-bills-cong116